Physicians

Department / Division
Medicine / Medicine - Oncology

Address
DUMC 3685
Durham, NC 27710

Appointment Telephone
919-668-6688

Office Telephone
919-668-6608

Fax Telephone
919-681-8167 (Clinic), 919-684-5163 (Office)

Training

• MD, Louisiana State University School of Medicine, 1980

Residency

• Internal Medicine, Louisiana State University Medical Center, 1981-1983

Fellowship

• Hematology/Oncology, Louisiana State University Medical Center, 1983-1985
• Oncology, MD Anderson Cancer Center (Texas), 1987-1989

Clinical Interests
Head and neck and thoracic cancer patients

Research Interests
Dr. Dunphy's research interests include conducting clinical research by designing therapies using new technologies and new drugs for patients with Lung malignancies and Head and Neck cancer.  The goal is to develop novel therapies that are simple to administer as an outpatient and to pursue organ preservation.

Industry Relationships and Collaborations (What's this?)

This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

• Amgen, Inc.

Representative Publications
5. Dunphy F, Dunleavy TL, Harrison BR, Cantrell CL, Visconti JL, Pincus SM, Richart JM, Petruska PJ. Phase I dose escalation study of topotecan combined with alternating schedules of paclitaxel and carboplatin in advanced solid tumors. Annals of Oncology 12:1-7, 2001. (2001)

4. Dunphy FR, Harrison BR, Dunleavy TL, Rodriguez JJ, Hilton JG, Boyd JH. Erythropoietin reduces anemia and transfusions: A randomized trial with or without erythropoietin during chemotherapy. Cancer 86(7):1362-7, 1999 October. (1999)

3. Dunphy FR, Dunleavy TL, Harrison BR, Kim HJ, Jerome DL, Rodriguez JJ, Boyd JH. Phase I report of ifosfamide combined with carboplatin for head and neck cancer. International Online Journal of Otorhinolaryngology-Head and Neck Surgery (www.orl-hns.org) 1(5), 1998 November. (1998)

1. Dunphy FR, Dunleavy TL, Harrison BR, Boy JH, Varvares MA, Dunphy CH, Rodriguez JJ, McDonough EM, Minster JR, McGrady MD. Erythropoietin reduces anemia and transfusions after chemotherapy with paclitaxel and carboplatin. Cancer 79(8):1623-8, 1997 Apr 15. (1997)

2. Dunphy FR, Boyd JH, Kim HJ, Dunphy CH, Harrison BR, Dunleavy TL, Rodriguez JJ, McDonough EM, Minster JR, Hilton JG. A phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinoma. Cancer 79(10):2016-23, 1997 May 15. (1997)